On April 1, 2026, Amanat Holdings PJSC issued a Board of Directors resolution by circulation. The resolution includes the approval of funding up to SAR 65 million for newly issued shares by its majority-owned subsidiary, Cambridge Health Group, to expand its Jeddah hospital by approximately 70 beds, including outpatient and surgical services. Additionally, the resolution approves an amendment to the existing Liquidity Provider Agreement with Al-Ramz Capital LLC, allowing the provider to buy and sell ordinary shares of the company up to 5% of the share capital. Other administrative and routine matters that do not affect the share price were also addressed.

Amanat Holdings PJSC held its Annual General Assembly on March 31, 2026, where shareholders approved various agenda items, including the Board of Directors' and Auditor's reports, financial statements for 2025, and a record cash dividend of AED 175 million (7% per share). The meeting, with an 84% quorum, also approved the Board's remuneration, discharged the Board and auditors from liability for 2025, appointed an external auditor for 2026, and authorized Board members to engage in competing businesses under certain conditions. Additionally, the appointment of Mr. John Ireland to the Board was ratified. Chairman Dr. Ali Saeed bin Harmal Aldhaheri and CEO John Ireland expressed gratitude for shareholder support and emphasized the company's focus on sustainable growth and shareholder returns. The resolutions will be submitted to regulatory authorities.

On March 27, 2026, a notification was sent to Mr. Hamed Ahmed Ali, the CEO of the Dubai Financial Market, regarding a resolution by circulation from the Board of Directors of Amanat Holdings PJSC. The resolution, scheduled for consideration on April 1, 2026, includes the following points: providing funding for expansion projects at the majority-owned subsidiary, Cambridge Health Group; amending the liquidity provider agreement with Al-Ramz Capital LLC, a related party transaction, to allow the provider to buy and sell ordinary shares of the company within legal limits; and addressing other administrative and routine matters that do not affect the share price. The notification was signed by Tessa Lee.

Cambridge Health Group, a subsidiary of Amanat Holdings PJSC, has completed the acquisition of the remaining minority interest in Sukoon International Holding Company, bringing its ownership to 100%. Amanat initially acquired a 33.25% stake in Sukoon in 2015, gradually increasing it to 90.50% by November 2025. The acquisition aligns with Cambridge Health Group's strategy to become a leading post-acute care provider, delivering significant financial growth in 2025. Cambridge Health Group operates six facilities in the UAE and Saudi Arabia, providing post-acute care, rehabilitation, and home healthcare services.

Cambridge Health Group has appointed Wael Abdallah as its Chief Executive Officer, effective immediately. Abdallah, who served as Interim CEO since February 2025 and was previously Chief Investment Officer, has been instrumental in the company's strategic development and operational performance. As CEO, he will focus on expanding the group's regional offerings, enhancing operational excellence, and maintaining high patient care standards. The appointment follows a period of strong growth for Cambridge Health Group, with significant financial performance improvements in 2025. The group plans to increase its operational capacity from 625 to approximately 725 beds in 2026 and aims to deliver more than 1,000 post-acute care beds in the future. It is also exploring expansion opportunities and plans to broaden its clinical services. Abdallah expressed his commitment to building on the company's strong foundations and delivering outstanding patient outcomes.

A proxy form is presented for shareholders of Amanat Holdings PJSC to appoint a representative to vote on their behalf at the General Assembly meeting scheduled for Tuesday, March 31, 2026, or any subsequent adjourned meeting. The form requires details such as the shareholder's or investor's number, contact information for both the shareholder and the proxyholder, and the date and signature. Additionally, it includes a section for the name and contact details of the financial broker or entity that verified the proxy.

Amanat Holdings PJSC, a leading investment company in healthcare and education, has appointed Dr. Ali Saeed Bin Harmal Aldhaheri as the new Chairman of its Board of Directors, effective immediately. This decision follows a board meeting on February 12, 2026. Dr. Ali has been a board member since November 2020 and has extensive experience in education and business sectors. He replaces Dr. Shamsheer Vayalil, who is stepping down to focus on other business interests. Under Dr. Shamsheer's leadership, Amanat successfully implemented strategies that enhanced shareholder value, including divesting an education real estate asset and listing its education business, Almasar Alshamil Education, on the Saudi Exchange. Dr. Ali expressed his commitment to continuing the company's growth and profitability. He also holds several other prominent positions, including roles in education and investment sectors, and has an MBA from the American University in Washington DC and a PhD from Durham University.

Amanat Holdings PJSC reported strong financial results for the fiscal year 2025, ending December 31. The company, a leading healthcare and education investment firm, saw a 17% increase in revenue from continuing operations, reaching AED 931.7 million. EBITDA grew by 28% to AED 380.4 million, and profit from continuing operations rose 42% to AED 248.1 million. The company completed its monetization cycle, resulting in cash and bank balances of AED 1.45 billion, and proposed a record dividend of AED 175 million, pending shareholder approval. Strategically, Amanat completed the IPO of Almasar Alshamil Education on the Saudi Exchange, exited non-core real estate investments, and strengthened its balance sheet to enhance shareholder distributions and reinvestment opportunities. In healthcare, the Cambridge Health Group expanded its operational bed capacity and increased EBITDA, with further growth anticipated. In education, student enrollments rose 20% to 27.9 thousand, with significant growth across its institutions and plans to expand SEN facilities. These accomplishments position Amanat for scalable growth in the future.

Amanat Holdings PJSC has released its consolidated financial statements for the year ending on December 31, 2025. Additional information can be found on their website, www.amanat.com.